3 August 2020 Analysis
Revitope and Junshi have teamed up to create next-generation T-cell engager cancer therapies; for the use of its TEAC platform, Revitope will be eligible for $160m in milestone payments. How...
31 July 2020 Comment
AstraZeneca and Daiichi Sankyo enter $6bn collaboration as pharma bets big on antibody-drug conjugates
On July 27, AstraZeneca announced that it had entered a new global development and commercialisation agreement with Daiichi Sankyo Company for DS-1062, Daiichi Sankyo’s proprietary trophoblast cell-surface antigen 2 (TROP2)-directed...
29 July 2020 Analysis
Sanofi has licensed Kiadis’s modified K-NK cell therapies to combine with its anti-CD38 antibody Sarclissa in multiple myeloma. How could this combination approach improve treatment outcomes for these blood cancer...
28 July 2020 Analysis
Cancer treatment has been traditionally characterised by surgery, chemotherapy and radiation. In the late 20th century, however, a fourth element entered the mainstream: immunotherapies. Allie Nawrat looks back at the...
27 July 2020 Comment
Biotech company initial public offering (IPO) valuations have shown resilience during the COVID-19 pandemic, compared to other industries. This is largely due to the unique nature of pharmaceuticals and the...
22 July 2020 Comment
The total number of confirmed cases of COVID-19 continue to rise globally with over 14.5 million cases now reported across 190 countries. Australia’s initial response to the novel virus was...
20 July 2020 Comment
Newly proposed lung cancer screening guidelines expected to double the number of Americans eligible for screening
Lung cancer, which is responsible for more than 145,000 deaths per year, is the most fatal type of cancer in the US. The US Preventive Services Task Force (USPSTF) proposed...
20 July 2020 Analysis
Artiva is working on bringing off-the-shelf NK cell therapies to cancer patients, supported by the manufacturing expertise of GC LabCell. To fund Artiva’s progression of three lead candidates to clinical...
13 July 2020 News
Amgen has made an additional investment of approximately $421m in Chinese biotechnology firm BeiGene's registered direct offering of ordinary shares.
9 July 2020 Comment
Earlier this week, the number of coronavirus disease 2019 (COVID-19) deaths in Mexico surpassed France, making it the country with the fifth highest number of COVID-19 deaths. Mexico currently has...